Skip to main content
. 2019 Jun 2;10(14):3140–3144. doi: 10.7150/jca.30355

Fig 2.

Fig 2

Kaplan-Meier curves of progression-free survival (PFS) from etoposide plus cisplatin based on primary tumor site of GEP-NEC